CYP1B1 and breast angiosarcoma: Of note, another CYP1B1 missense variant of rs1056836-G (V432L) was previously associated with BA susceptibility through a candidate gene approach (p=0.045),45 of which independent protective effect was also confirmed in our study (p=2.7×10-5).